Nausea News and Research

RSS

Nausea is the sensation of unease and discomfort in the upper stomach and head with an urge to vomit. An attack of nausea is known as a qualm.

New app focuses on supporting patients with life-limiting illnesses in Ethiopia

The Ayzot app is a collaboration between Surrey, the University of Strathclyde, Hospice Ethiopia, the Federal Ministry of Health and Hello Doctor Ethiopia, an Ethiopian-based software company run by Dr Yohans Wodaje.

13 May 2021

Huge healthcare burden of post-COVID-19 symptoms likely, suggests new study

How well do patients who had COVID-19 recover after the virus is cleared from their systems? A new preprint reports on symptom profiles over the first nine months of the illness.

13 May 2021

Black collegiate-athletes found to have lower concussion symptom knowledge than White counterparts

Among collegiate football players and other athletes, Black athletes recognize fewer concussion-related symptoms than their White counterparts, reports a study in the May/June issue of the Journal of Head Trauma Rehabilitation.

7 May 2021

Improved drug to counteract the side effects of spinal anesthesia during C-sections

Today, deliveries via cesarean sections, or c-sections, have become quite common globally. Sometimes, c-sections are a medical necessity when normal deliveries become risky either for the mother or the baby.

7 May 2021

Study reveals sex differences in evaluation and treatment of young adults with chest pain

Among younger adults visiting the emergency department for chest pain, women may be getting the short end of the stick.

6 May 2021

New NCCN patient guidelines on anemia and neutropenia published

The National Comprehensive Cancer Network announced today the publication of new NCCN Guidelines for Patients: Anemia and Neutropenia, Low Red and White Blood Cell Counts funded by the NCCN Foundation and endorsed by The Leukemia and Lymphoma Society (LLS).

3 May 2021

Chemotherapy drugs delivered via nanoparticles could improve bowel cancer survival rates

Bowel cancer survival rates could be improved if chemotherapy drugs were delivered via tiny nanoparticles to the diseased organs rather than oral treatment.

3 May 2021

FDA approves higher dose naloxone hydrochloride nasal spray product to combat opioid overdose

The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose. The newly approved product delivers 8 milligrams (mg) of naloxone into the nasal cavity. The FDA had previously approved 2 mg and 4 mg naloxone nasal spray products.

30 Apr 2021

Study examines mRNA COVID-19 vaccine’s effectiveness across age and gender

The findings reveal that although the two-dose vaccine regimen initially induces robust antibody response in all age groups, older male individuals are particularly associated with a gradual decline in vaccine-induced immunity six weeks after the second vaccine dose.

28 Apr 2021

Real-world study in India finds COVISHIELD vaccine safe and effective

New research led by Naresh Trehan of Medanta-The Medicity in India found the COVISHIELD (ChAdOx1 nCoV-19 Corona Virus Vaccine) vaccine produced an immune response from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) two weeks after vaccination with limited side effects.

26 Apr 2021

Researchers harness the body's own ability to block pain

Fentanyl, oxycodone, morphine--these substances are familiar to many as a source of both pain relief and the cause of a painful epidemic of addiction and death.

26 Apr 2021

Babies born to mothers with cannabis use disorder more likely to experience negative health outcomes

A study of almost 5 million live births in California by researchers at the Herbert Wertheim School of Public Health and Human Longevity Science at University of California San Diego reports that babies born to mothers diagnosed with cannabis use disorder were more likely to experience negative health outcomes, such as preterm birth and low birth weight, than babies born to mothers without a cannabis use disorder diagnosis.

22 Apr 2021

FDA approves immunotherapy for treating patients with dMMR endometrial cancer

Today, the U.S. Food and Drug Administration granted accelerated approval to Jemperli (dostarlimab) for treating patients with recurrent or advanced endometrial cancer that has progressed on or following prior treatment with a platinum-containing chemotherapy and whose cancers have a specific genetic feature known as dMMR (which contain abnormalities that affect the proper repair of DNA inside the cell), as determined by an FDA-approved test.

22 Apr 2021

Researchers aim to better understand clinical features associated with COVID-19 mortality

To better understand the COVID-19 clinical feaures associated with mortality, an interdisciplinary team of researchers has investigated important factors and their influence on a patient’s death.

22 Apr 2021

From rotten teeth to advanced cancer, patients feel the effects of treatment delays

With medical visits picking up again among patients vaccinated against Covid-19, health providers are starting to see the consequences of a year of pandemic-delayed preventive and emergency care as they find more advanced cancer and rotting and damaged teeth, among other ailments.

20 Apr 2021

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma.

16 Apr 2021

Leaky gut and microbial dysbiosis could contribute to cytokine storm in severely ill COVID-19 cases

The gut is a well-established route of infection and target for viral damage by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent for COVID-19. This is supported by the clinical observation that about half of COVID-19 patients exhibit gastrointestinal (GI) symptoms.

8 Apr 2021

Nausea News and Research

Further Reading

New app focuses on supporting patients with life-limiting illnesses in Ethiopia

Huge healthcare burden of post-COVID-19 symptoms likely, suggests new study

Black collegiate-athletes found to have lower concussion symptom knowledge than White counterparts

Improved drug to counteract the side effects of spinal anesthesia during C-sections

Study reveals sex differences in evaluation and treatment of young adults with chest pain

New NCCN patient guidelines on anemia and neutropenia published

Chemotherapy drugs delivered via nanoparticles could improve bowel cancer survival rates

FDA approves higher dose naloxone hydrochloride nasal spray product to combat opioid overdose

Study examines mRNA COVID-19 vaccine’s effectiveness across age and gender

Real-world study in India finds COVISHIELD vaccine safe and effective

Researchers harness the body's own ability to block pain

Babies born to mothers with cannabis use disorder more likely to experience negative health outcomes

FDA approves immunotherapy for treating patients with dMMR endometrial cancer

Researchers aim to better understand clinical features associated with COVID-19 mortality

From rotten teeth to advanced cancer, patients feel the effects of treatment delays

FDA approves immunotherapy for first-line treatment of advanced gastric cancer

Leaky gut and microbial dysbiosis could contribute to cytokine storm in severely ill COVID-19 cases

AGA’s new clinical guidelines recommend the use of IGB for obese patients

COVID-19 patients with dementia have higher risk for complications, mortality

Protein could be key to blocking the most common bacterial cause of food poisoning

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News